Morales’s protocol of 6-weekly intravesical instillations of bacillus Calmette–Guerin (BCG), introduced in 1976, has survived to this date. BCG is superior to chemotherapy as an adjuvant agent ...

Adjuvant, intravesical bacillus Calmette–Guérin (BCG ... the 35 patients who received intravesical BCG therapy (mean 8 instillations, range 1–20) had markedly improved recurrence-free ...

and has a favorable safety profile when compared with intravesical therapy using live bacillus Calmette–Guérin (BCG), reports Alvaro Morales and colleagues. Intravesical administration of BCG ...

followed by additional instillations (maintenance therapy) every three or six months or monthly for one to three years. Intravesical bacillus Calmette-Guerin (tuberculosis vaccine) has been used ...

Therapeutic options to treat intermediate-risk and BCG-unresponsive bladder cancer, such as medications and ablative therapies, are expanding, and novel PET tracers enable improved diagnosis and ...

Bacillus of Calmette and Guerin (BCG) strain of Mycobacterium bovis live, attenuated culture preparation; 50mg per vial; pwd for intravesical administration after reconstitution and dilution ...